Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Centocor

This article was originally published in The Gray Sheet

Executive Summary

Centocor: Plans spin-out of shares in its Centocor Diagnostics subsidiary via an initial public offering of Class A common stock, the firm states in an Oct. 16 release. Centocor expects to retain a "greater than 80% voting control" in the business upon completion of the offering. Proceeds from the offering would go towards Centocor Diagnostics' cardiovascular diagnostic program, working capital, R&D and "other general corporate purposes," Centocor states. Morgan Stanley Dean Witter and Credit Suisse First Boston are managing the offering...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel